Single award · contract

Advanced Research and Development and Delivery of Adult and Pediatric Midazolam Autoinjectors That Have…

Award ID: 75A50122C00031

FY2022 · complete year · data as of 2026-07-11

A single federal award, with both ends of the trail linked.

$108.8M
Total award value

Award 75A50122C00031 is a contract from the Department of Health and Human Services, $108.8M obligated, FY2022 to FY2030, for Advanced Research and Development and Delivery of Adult and Pediatric Midazolam Autoinjectors That…. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN13 (Health R&D Services; Health Care Services; Experimental Development). Source

Description

Advanced Research and Development and Delivery of Adult and Pediatric Midazolam Autoinjectors That Have Received Emergency Use Authorization (EUA) or FDA Approval for the Treatment of Status Epilepticus Seizures in Adult and Pediatric Populations (2+

Award details

Award typeContract
PIID75A50122C00031
Action date2022
Period96 mo
RecipientOutside our Phase 1 contractor set: see methodology
Place of performance—
Competed?Not recordedSource
Total (exact)$108,841,769

More from Department of Health and Human Services

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.